A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation

Human Molecular Genetics

Volumn 24, Issue 1, 2015, Pages 1-8

  Gehlhausen, Jeffrey R ^a   Park, Su Jung ^a   Hickox, Ann E ^b,c   Shew, Matthew ^a   Staser, Karl ^a   Rhodes, Steven D ^a   Menon, Keshav ^a   Lajiness, Jacquelyn D ^a   Mwanthi, Muithi ^a   Yang, Xianlin ^a   Yuan, Jin ^a   Territo, Paul ^a   Hutchins, Gary ^a   Nalepa, Grzegorz ^a   Yang, Feng Chun ^a   Conway, Simon J ^a   Heinz, Michael G ^b,c   Stemmer Rachamimov, Anat ^d   Yates, Charles W ^a   Clapp, D Wade ^a,e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; MERLIN; POSTN PROTEIN, MOUSE;

ACOUSTIC NEURINOMA; ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; AUDITORY SCREENING; BALANCE IMPAIRMENT; BRAIN STEM RESPONSE; CARCINOGENESIS; CONTROLLED STUDY; CRANIAL NERVE TUMOR; FUNCTIONAL HEARING LOSS; GENE EXPRESSION; HISTOPATHOLOGY; MOLECULAR PATHOLOGY; MOUSE; MOUSE MODEL; NERVE TUMOR; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 2 GENE; NONHUMAN; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHWANN CELL; SPINAL NERVE; SPINAL NERVE TUMOR; TUMOR SUPPRESSOR GENE; VESTIBULAR TEST; ANIMAL; COMPLICATION; DISEASE MODEL; EXON; GENETICS; HEARING; HUMAN; MUTATION; NEUROFIBROMATOSIS TYPE 2; NEUROMA; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL GANGLION; TRANSGENIC MOUSE; VESTIBULOCOCHLEAR NERVE;

ANIMALIA; MURINAE; MUS;

ANIMALS; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; EXONS; GANGLIA, SPINAL; HEARING; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; NEUROMA, ACOUSTIC; VESTIBULOCOCHLEAR NERVE;

EID: 84922503965     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu414     Document Type: Article

References (30)

1. Asthagiri, A.R., Parry, D.M., Butman, J.A., Kim, H.J., Tsilou, E.T., Zhuang, Z. and Lonser, R.R. (2009) Neurofibromatosis type 2. Lancet, 373, 1974-1986.
2. Di Maio, S. and Akagami,R. (2009) Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. J. Neurosurg., 111, 855-862.
3. Sharpless, N.E. and Depinho, R.A. (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug. Discov., 5, 741-754.
4. Giovannini, M., Robanus-Maandag, E., Niwa-Kawakita, M., van der Valk, M., Woodruff, J.M., Goutebroze, L., Merel, P., Berns, A. and Thomas, G. (1999) Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev., 13, 978-986.
5. Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J.M., Berns, A. and Thomas, G. (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev., 14, 1617-1630.
6. Lindsley, A., Snider, P., Zhou, H., Rogers, R., Wang, J., Olaopa, M., Kruzynska-Frejtag, A., Koushik, S.V., Lilly, B., Burch, J.B. et al. (2007) Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev. Biol., 307, 340-355.
7. Stemmer-Rachamimov, A.O., Ino, Y., Lim, Z.Y., Jacoby, L.B., MacCollin, M., Gusella, J.F., Ramesh, V. and Louis, D.N. (1998) Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2. J. Neuropathol. Experim. Neurol., 57, 1164-1167.
8. Tsai, H., Hardisty, R.E., Rhodes, C., Kiernan, A.E., Roby, P., Tymowska-Lalanne, Z., Mburu, P., Rastan, S., Hunter, A.J., Brown, S.D. et al. (2001) The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum. Mol. Genet., 10, 507-512.
9. Stemmer-Rachamimov, A.O., Louis, D.N., Nielsen, G.P., Antonescu, C.R., Borowsky, A.D., Bronson, R.T., Burns, D.K., Cervera, P., McLaughlin, M.E., Reifenberger, G. et al. (2004) Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res., 64, 3718-3724.
10. Sperfeld, A.D., Hein, C., Schroder, J.M., Ludolph, A.C. and Hanemann,C.O. (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain, 125, 996-1004.
11. Zheng, Q.Y., Johnson, K.R. and Erway, L.C. (1999) Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hearing Res., 130, 94-107.
12. Henry, K.R. (1979) Auditory brainstem volume-conducted responses: origins in the laboratory mouse. J. Am. Audit. Soc., 4, 173-178.
13. Melcher, J.R. and Kiang, N.Y. (1996) Generators of the brainstem auditory evoked potential in cat. III: identified cell populations. Hearing Res., 93, 52-71.
14. Santarelli, R., Del Castillo, I., Rodriguez-Ballesteros, M., Scimemi, P., Cama, E., Arslan, E. and Starr, A. (2009) Abnormal cochlear potentials from deaf patients with mutations in the otoferlin gene. J. Assoc. Res. Otolaryngol., 10, 545-556.
15. Durrant, J.D., Wang, J., Ding, D.L. and Salvi, R.J. (1998) Are inner or outer hair cells the source of summating potentials recorded from the round window? J. Acoust. Soc. Am., 104, 370-377.
16. Vidal, P.P., Degallaix, L., Josset, P., Gasc, J.P. and Cullen, K.E. (2004) Postural and locomotor control in normal and vestibularly deficient mice. J. Physiol., 559, 625-638.
17. Hardisty-Hughes, R.E., Parker, A. and Brown, S.D. (2010) A hearing and vestibular phenotyping pipeline to identify mouse mutants with hearing impairment. Nat. Protoc., 5, 177-190.
18. Jessen, K.R. and Mirsky, R. (2005) The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci., 6, 671-682.
19. Yang, F.C., Ingram, D.A., Chen, S., Zhu, Y., Yuan, J., Li, X., Yang, X., Knowles, S., Horn, W., Li, Y. et al. (2008) Nf1-dependent tumors require a microenvironment containing Nf1 +/- and c-kit-dependent bone marrow. Cell, 135, 437-448.
20. Pollizzi, K., Malinowska-Kolodziej, I., Doughty, C., Betz, C., Ma,J., Goto, J. and Kwiatkowski, D.J. (2009) A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles. Hum. Mol. Genet., 18, 2378-2387.
21. Mo,W., Chen, J., Patel, A., Zhang, L., Chau, V., Li, Y., Cho, W., Lim, K., Xu, J., Lazar, A.J. et al. (2013) CXCR4/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell, 152, 1077-1090.
22. Lee da, Y., Gianino, S.M. and Gutmann, D.H. (2012) Innate neural stem cell heterogeneity determines the patterning of glioma formation in children. Cancer Cell, 22, 131-138.
23. Wu, J., Williams, J.P., Rizvi, T.A., Kordich, J.J., Witte, D., Meijer, D., Stemmer-Rachamimov, A.O., Cancelas, J.A. and Ratner, N. (2008) Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell, 13, 105-116.
24. Birnbaum, R.A., O'Marcaigh, A., Wardak, Z., Zhang, Y.Y., Dranoff, G., Jacks, T., Clapp, D.W. and Shannon, K.M. (2000) Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol. Cell, 5, 189-195.
25. Seizinger, B.R., Rouleau, G., Ozelius, L.J., Lane, A.H., St George-Hyslop, P., Huson, S., Gusella, J.F. and Martuza, R.L. (1987) Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science, 236, 317-319.
26. Fisher, L.M., Doherty, J.K., Lev, M.H. and Slattery, W.H. (2009) Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium. Otol. Neurotol., 30, 835-841.
27. Plotkin, S.R., Stemmer-Rachamimov, A.O., Barker, F.G. 2nd, Halpin, C., Padera, T.P., Tyrrell, A., Sorensen, A.G., Jain, R.K. and di Tomaso,E. (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N. Engl. J. Med., 361, 358-367.
28. Asthagiri, A.R., Vasquez, R.A., Butman, J.A., Wu, T., Morgan, K., Brewer, C.C., King, K., Zalewski, C., Kim, H.J. and Lonser, R.R. (2012) Mechanisms of hearing loss in neurofibromatosis type 2. PloS one, 7, e46132.
29. Gouveris, H.T., Victor, A. and Mann, W.J. (2007) Cochlear origin of early hearing loss in vestibular schwannoma. Laryngoscope, 117, 680-683.
30. Prasher, D.K., Tun, T., Brookes, G.B. and Luxon, L.M. (1995) Mechanisms of hearing loss in acoustic neuroma: an otoacoustic emission study. Acta Otolaryngol., 115, 375-381.